A Phase 1, Single Center, Double-blind, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Effects of Single Oral Doses of AEF0117 in Healthy Male and Female Subjects

Trial Profile

A Phase 1, Single Center, Double-blind, Placebo-controlled, Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Effects of Single Oral Doses of AEF0117 in Healthy Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2018

At a glance

  • Drugs AEF 0117 (Primary)
  • Indications Drug abuse
  • Focus Adverse reactions
  • Sponsors Aelis Farma
  • Most Recent Events

    • 12 Mar 2018 Status changed from recruiting to completed.
    • 15 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Jul 2018.
    • 15 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top